References
- T. D. Warner and J. A. Mitchell, Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic, FASEB J. 18 (2004) 790-804.
- E. M. Antman, D. DeMets and J. Loscalzo, Cyclooxygenase inhibition and cardiovascular risk, Circulation 112 (2005) 759-770.
- J. J. Li, G. D. Anderson, E. G. Burton, J. N. Cogburn, J. T. Collins, D. J. Garland, S. A. Gregory, H. C. Huang, P. C. Isakson, C. M. Koboldt, E. W. Logusch, M. B. Norton, W. E. Perkins, E. J. Reinhard, K. Seibert, A. W. Veenhuizen, Y. Zhang and D. B. Reitz, 1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents, J. Med. Chem. 38 (1995) 4570-4578.
- T. D. Penning, J. J. Talley, S. R. Bertenshaw, J. S. Carter, P. W. Collins, S. Docter, M. J. Graneto, F. J. Lee, J. W. Malecha, J. M. Miyashiro, R. S. Rogers, D. J. Rogier, S. S. Yu, G. A. Anderson, F. G. Burton, J. N. Cogburn, S. A. Gragory, C. M. Koboldt, W. E. Perkins, K. Seibert, A. W. Veenhuizen, Y. Y. Zhang and P. C. Isakson, Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl) -1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib), J. Med. Chem. 40 (1997) 1347-1365.
- G. Dannhardt and W. Kiefer, Cyclooxygenase inhibitors - current status and future prospects, Eur. J. Med. Chem. 36 (2001) 109-126.
- P. Prasit, Z. Wang, C. Brideau, C. C. Chan, S. Charleson, W. Cromlish, D. Either, J. F. Evans, A. W. Ford-Hutchinson, J. Y. Gauthier, R. Gordon, J. Guay, M. Gresser, S. Kargman, B. Kennedy, Y. Leblanc, S. Leger, J. Mancini, G. P. O'Neil, M. Ouellet, M. D. Percieval, H. Perrier, D. Riendeau, I. Rodger, P. Tagari, M. Therien, P. Vickers, E. Wong, L. J. Xu, R. N. Young, R. Zamboni, S. Boyce, N. Rupniak, M. Forrest, D. Visco and D. Patrick, The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxy-genase-2 inhibitor, Bioorg. Med. Chem. Lett. 9 (1999) 1773-1778.
- J. J. Tally, D. L. Brown, J. S. Carter, M. J. Graneto, C. M. Koboldt, J. L. Masferrer, W. E. Perkins, R. S. Rogers, A. F. Shaffer, Y. Y. Zhang, B. S. Zweifel and K. Seibert, 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2, J. Med. Chem. 43 (2000) 775-777.
- J. J. Tally, S. R. Bertenshaw, D. L. Brown, J. S. Carter, M. J. Graneto, M. S. Kellogg, C. M. Koboldt, J. Yuan, Y. Y. Zhang and K. Seibert, N[[(5-Methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration, J. Med. Chem. 43 (2000) 1661-1663.
- D. Riendeau, M. D. Percieval, C. Brideau, S. Charleson, D. Dube, D. Ethier, J. P. Falgueyret, R. W. Friesen, R. Gordon, G. Greig, J. Guay, J. Mancini, M. Ouellet, E. Wong, L. J. Xu, S. Boyce, D. Visco, Y. Girard, P. Prasit, R. Zamboni, I. W. Rodger, M. Gresser, A. W. Ford-Hutchinson, R. N. Young and C. C. Chan, Etoricoxib (MK-0663): Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2, J. Pharmacol. Exp. Ther. 296 (2001) 558-570.
- M. R. Yadav, R. Giridhar and H. B. Prajapati, A Process for Preparation of 3-[-o-/m-/p-Mono/DisubstitutedPhenyl]-4-[o-/p-Substitutedphenyl]furazans and Furoxans, Indian Patent Appl. No. 109/MUM/2004, Feb. 2004.
- H. Cerecetto and W. Porcal, Pharmacological properties of furoxans and benzofuroxans: Recent developments, Mini-Rev. Med. Chem. 5 (2005) 57-71.
- V. G. Granik and N. B. Grigor, Nitric oxide synthase inhibitors: Biology and Chemistry, Russ. Chem. Bull. 51 (2002) 1973-1995.
- C. Velazquez, P. N. P. Rao, R. McDonald and E. E. Knaus, Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents, Bioorg. Med. Chem. 13 (2005) 2749-2757.
- J. S. Buck and W. S. Ide, Mixed benzoins. I, J. Am. Chem. Soc. 52 (1930) 220-224.
- J. S. Buck and W. S. Ide, Mixed benzoins. II, J. Am. Chem. Soc. 52 (1930) 4107-4109.
- S. T. Shirude, P. Patel, R. Giridhar and M. R. Yadav, An efficient and time saving microwave assisted selenium dioxide oxidation of 1,2-diarylethanones, Indian. J. Chem. 45B (2006) 1080-1085.
- H. Sano, T. Noguchi, A. Tanatani, Y. Hashimoto and H. Miyachi, Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide, Bioorg. Med. Chem. 13 (2005) 3079-3091.
- C. A. Winter, E. A. Risley and G. W. Nuss, Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs, Proc. Soc. Exp. Biol. Med. 111 (1962) 544-547.
- SYBYL Molecular modeling system, version 6.9, Tripos, Inc., St. Louis, USA, (2003).
- R. A. Friesner, J. L. Banks, R. B. Murphy, T. A. Halgren, J. J. Klicic, D. T. Mainz, M. P. Repasky, E. H. Knoll, M. Shelly, J. K. Perry, D. E. Shaw, P. Francis and P. S. Shenkin, Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Chem. 47 (2004) 1739-1749.
- M. Clark, R. D. Crammer and N. van Opdenbosh, Validation of the General-Purpose Tripos 5.2 force field, J. Comput. Chem. 10 (1989) 982-1012.
- J. H. Boyer, R. F. Reinisch, M. J. Danzig, G. A. Stoner and F. Sahhar, The transformation of ψ-o-dinitroso aromatic compounds into o-nitroaryl amines, J. Am. Chem. Soc. 77 (1955) 5688-5690.